HCA Healthcare, Inc. Quarterly Report for Q2 Ended Jun 30, 2016

Summary

HCA Healthcare, Inc. reported strong financial performance for the second quarter and first six months of 2016, with revenues increasing by 4.3% and 5.1% respectively, compared to the prior year periods. Net income attributable to HCA Holdings, Inc. also saw significant growth, up 29.8% for the quarter and 23.1% for the six-month period, driven by increased patient volumes and revenue per equivalent admission. The company continued its share repurchase program, demonstrating a commitment to returning capital to shareholders. While operational performance was robust, investors should note the ongoing legal proceedings, particularly the Health Midwest litigation, which resulted in a significant accrued liability. The company's substantial debt load remains a key consideration for financial health. Despite these factors, HCA Healthcare's financial results indicate a healthy operational performance and a positive outlook for the period.

Key Highlights

• 1Revenues increased by 4.3% to $10.319 billion for Q2 2016 and by 5.1% to $20.579 billion for the first six months of 2016, compared to the prior year periods.
• 2Net income attributable to HCA Holdings, Inc. grew significantly, up 29.8% to $658 million for Q2 2016 and 23.1% to $1.352 billion for the first six months of 2016.
• 3Diluted EPS rose to $1.65 for Q2 2016 and $3.34 for the first six months of 2016, up from $1.18 and $2.54, respectively, in the prior year periods.
• 4The company actively engaged in share repurchases, buying back 24.4 million shares in the first six months of 2016.
• 5Operating cash flow saw a substantial increase of $673 million in the first six months of 2016 compared to the same period in 2015.
• 6The company's substantial long-term debt of $31.228 billion as of June 30, 2016, remains a key financial consideration.

Frequently Asked Questions